English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  52177247    在线人数 :  774
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

跳至: [ 中文 ] [ 数字0-9 ] [ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z ]
请输入前几个字:   

显示项目 703356-703365 / 2348487 (共234849页)
<< < 70331 70332 70333 70334 70335 70336 70337 70338 70339 70340 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2018-09-10T08:21:41Z Quality-adjusted life expectancy (QALE) and loss of qale for patients with ischemic stroke and intracerebral hemorrhage: A 13-year follow-up Lee, H.-Y. and Hwang, J.-S. and Jeng, J.-S. and Wang, J.-D.; JIANN-SHING JENG
臺大學術典藏 2010 Quality-adjusted life expectancy (QALE) and loss of qale for patients with ischemic stroke and intracerebral hemorrhage: A 13-year follow-up Lee H.-Y.;Hwang J.-S.;Jiann-Shing Jeng;Wang J.-D.; Lee H.-Y.; Hwang J.-S.; JIANN-SHING JENG; Wang J.-D.
臺大學術典藏 2021-12-22T03:54:27Z Quality-adjusted life expectancy (QALE) and loss of qale for patients with ischemic stroke and intracerebral hemorrhage: A 13-year follow-up Lee H.-Y.; Hwang J.-S.; JIANN-SHING JENG; Wang J.-D.
國立臺灣大學 2009 Quality-Adjusted Life Years Saved by Prevention of Head Injury through Enforcement of Helmet Law 李昕怡; 王榮德; LEE, HSIN-YI; WANG, JUNG-DER
國立臺灣大學 2010 Quality-adjusted life-years and helmet use among motorcyclist sustaining head injuries 李昕怡; 陳業欣; 邱文達; 黃景祥; 王榮德; LEE, HSIN-YI; CHEN, YEH-HSIN; CHIU, WEN-TA; HWANG, JING-SHIANG; WANG, JUNG-DER
國立臺灣大學 2010 Quality-Adjusted Life-Years and Helmet Use among Motorcyclists Sustaining Head Injuries 李昕怡; 陳業欣; 邱文達; 黃景祥; 王榮德; LEE, HSIN-YI; CHEN, YEH-HSIN; CHIU, WEN-TA; HWANG, JING-SHIANG; WANG, JUNG-DER
臺大學術典藏 2020-02-25T09:08:37Z Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non–Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/Carboplatin Hirsh, V.; Wan, Y.; FANG-JU LIN; Margunato-Debay, S.; Ong, T.J.; Botteman, M.; Langer, C.
國家衛生研究院 2017-05 Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: A Q-TWiST analysis Pelzer, U;Blanc, JF;Melisi, D;Cubillo, A;Von Hoff, DD;Wang-Gillam, A;Chen, LT;Siveke, JT;Wan, Y;Solem, CT;Botteman, MF;Yang, Y;de Jong, FA;Hubner, RA
國家衛生研究院 2016-05 Quality-adjusted time without symptoms or toxicity (Q-TWiST) of nanoliposomal irinotecan (nal-IRI; MM-398) plus 5-fluorouracil and leucovorin (5-FU/LV) vs 5-FU/LV alone in metastatic pancreatic adenocarcinoma (mPAC) patients (pts) previously treated with Pelzer, U;Blanc, JF;Melisi, D;Cubillo, A;Von Hoff, DD;Wang-Gillam, A;Chen, LT;Siveke, JT;Wan, Y;Solem, CT;Botteman, M;Yang, Y;de Jong, F;Hubner, R
國家衛生研究院 2016-10 Quality-adjusted time without symptoms or toxicity (Q-TWIST) of nanoliposomal irinotecan (nal-IRI;MM-398) plus 5-fluorouracil and leucavorin (5-FU/LV) vs 5-FU/LV alone in patients with metastatic pancreatic adenocarcinoma (mPAC) previously treated with ge Pelzer, U;Blanc, JF;Melisi, D;Cubillo, A;Von Hoff, DD;Wang-Gillam, A;Chen, LT;Siveke, JT;Wan, Y;Solem, CT;Botteman, M;Yang, Y;de Jong, F;Hubner, R

显示项目 703356-703365 / 2348487 (共234849页)
<< < 70331 70332 70333 70334 70335 70336 70337 70338 70339 70340 > >>
每页显示[10|25|50]项目